Literature DB >> 23065965

Histopathology of retinoblastoma: does standardization make a difference in reporting?

Sabyasachi Sengupta1, Subramanian Krishnakumar, Tarun Sharma, Lingam Gopal, Vikas Khetan.   

Abstract

The International Retinoblastoma Staging Working Group (IRSWG) provided guidelines for tissue handling of eyes enucleated for retinoblastoma. We adopted these guidelines from January 2009. Reviewing histopathology slides between January 2006 and December 2010 we found significantly more number of eyes with massive choroidal, optic nerve, and anterior segment invasion by tumor cells in the post-IRSWG era. The guidelines provided by the IRSWG; in addition to being standardized; recognize more eyes with histopathologic risk factors compared to techniques applied in the past. This may translate to more children receiving adjuvant chemotherapy and contribute to reduced mortality rates in the future.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23065965     DOI: 10.1002/pbc.24357

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

1.  Targeting HMGA2 in Retinoblastoma Cells in vitro Using the Aptamer Strategy.

Authors:  Venkatesan Nalini; Perinkulam Ravi Deepa; Rajeswari Raguraman; Vikas Khetan; Maddy Ashwin Reddy; Subramanian Krishnakumar
Journal:  Ocul Oncol Pathol       Date:  2016-07-02

2.  Effects of PPARγ agonistrosiglitazone on human retinoblastoma cell in vitro and in vivo.

Authors:  Xianyong Cao; Lin He; Yanhua Li
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  RNAi mediated Tiam1 gene knockdown inhibits invasion of retinoblastoma.

Authors:  Nithya Subramanian; Saranya Navaneethakrishnan; Jyotirmay Biswas; Rupinder K Kanwar; Jagat R Kanwar; Subramanian Krishnakumar
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

4.  Targeted expression of suicide gene by tissue-specific promoter and microRNA regulation for cancer gene therapy.

Authors:  Ravikanth Danda; Gopinath Krishnan; Kalaivani Ganapathy; Uma Maheswari Krishnan; Khetan Vikas; Sailaja Elchuri; Nivedita Chatterjee; Subramanian Krishnakumar
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.